Supplementary Figure S2

DU-145
Supplementary VCaP tumors compared to the BW before the treatments were calculated during the oral treatment with vehicle, enzalutamide (20 mg/kg, qd), or ODM-201 (50 mg/kg, qd or bid) for 37 days (n=8-10). *The mouse had to be euthanised before the end of the experiment due to a large tumor. † Data missing. Qd=once daily, bid=twice daily.
Supplementary Data 1 Description of the synthesis of ODM-201 and ORM-15341
2-Chloro-4-(1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl)benzonitrile
1-(tetrahydro-2H-pyran-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole (6.5 g;
23.28 mmol) and 4-bromo-2-chlorobenzonitrile (4 g; 18.48 mmol) were dissolved in THF (65 ml).
To this mixture bis(triphenylphosphine)palladium(II) chloride (0.65 g; 0.92 mmol), sodium carbonate (4.7 g; 44.3 mmol) and 18 ml of water were added and the reaction mixture was stirred at 35 ºC for 2.5 h. The solvents were distilled to almost dryness and water (48 ml) was added. After 30 min of stirring the precipitated product was filtered and 32 ml of ethanol was added to the precipitation. The suspension was stirred for 15 min at RT and 30 min at -10 ºC before filtering to give 3.7 g of the product. 
2-Chloro-4-(1H-pyrazol-5-yl)benzonitrile
2-Chloro-4-(1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl)benzonitrile (3.67 g; 12.75 mmol) was added to 8 ml of ethanol under nitrogen atmosphere. 15.5 ml of ~10 % HCl (g) in EtOH was slowly added and the temperature was raised to 30 ºC where the mixture was stirred for 1 h. The temperature was then lowered to -10 ºC and the mixture was again stirred for 30 min after which the product was precipitated as its HCl salt and was filtered and washed twice with 2 ml of ethanol. The product was dried in vacuo at +40ºC. Yield 2.8 g. 2-Chloro-4-(1H-pyrazol-5-yl)benzonitrile hydrochloride (2.8 g; 11.47 mmol) was added to a mixture of 8 ml of water and 14 ml of MeOH under nitrogen atmosphere. To this 50 % sodium hydroxide (1.5 ml; 28.7 mmol) was added keeping the temperature under 25 ºC during the addition. The mixture was stirred for 2 h, the precipitate filtered and washed twice with 3 ml of lukewarm water. The product was dried in vacuo at +40 ºC. to the evaporation residue, stirred for 20 h at RT and evaporated to dryness. 100 ml of water was added to the evaporation residue and washed with 3 x 120ml of DCM to remove reactant residues.
pH of water phase was adjusted to ~12 by addition of 2 M NaOH, washed with 3 x 80 ml of DCM and organic phase dried over Na 2 SO 4 . Organic phase was filtered and evaporated to give 2.605 g of the title compound.
(S) -3-acetyl-N-(1-(3-(3-chloro-4-cyanophenyl 
3-Acetyl-1H-pyrazole-5-carboxylic acid (0.59 g; 3.84 mmol) and DIPEA (1.0 ml; 5.75 mmol) were dissolved in 4 ml of dry DCM. Anhydrous HOBt (0.78 g; 5.75 mmol) and EDCI (1.10 g; 5.75 mmol) were added at RT. (S)-4-(1-(2-aminopropyl)-1H-pyrazol-3-yl)-2-chlorobenzonitrile (1.00 g; 3.84 mmol) was dissolved in 4 ml of DCM and the reaction was stirred for overnight at RT. 40 ml of DCM was added and organic layer washed with 3 x 15 ml of water. Combined water phases were washed with 2 x 20 ml of DCM. Both organic phases were dried over Na 2 SO 4 , filtered and evaporated to dryness. Both crude product fractions were combined and purified by CombiFlash (2 % MeOH in DCM). Product fractions were combined and evaporated to give 497mg of product.
